FDA Issues New Warning on Misuse of Johnson & Johnson Skin Patch

WASHINGTON (Reuters) - U.S. health officials issued a second warning on Friday about reports of deaths and dangerous side effects in patients who used Johnson & Johnson’s (JNJ.N: Quote, Profile, Research) Duragesic pain-killing skin patch or generic versions.

MORE ON THIS TOPIC